263 related articles for article (PubMed ID: 22614014)
1. Macrophage cathepsin K promotes prostate tumor progression in bone.
Herroon MK; Rajagurubandara E; Rudy DL; Chalasani A; Hardaway AL; Podgorski I
Oncogene; 2013 Mar; 32(12):1580-93. PubMed ID: 22614014
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.
Podgorski I; Linebaugh BE; Koblinski JE; Rudy DL; Herroon MK; Olive MB; Sloane BF
Am J Pathol; 2009 Sep; 175(3):1255-69. PubMed ID: 19700761
[TBL] [Abstract][Full Text] [Related]
3. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.
Hardaway AL; Herroon MK; Rajagurubandara E; Podgorski I
Clin Exp Metastasis; 2015 Apr; 32(4):353-68. PubMed ID: 25802102
[TBL] [Abstract][Full Text] [Related]
4. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
5. Prostate Tumor Cell-Derived IL1β Induces an Inflammatory Phenotype in Bone Marrow Adipocytes and Reduces Sensitivity to Docetaxel via Lipolysis-Dependent Mechanisms.
Herroon MK; Diedrich JD; Rajagurubandara E; Martin C; Maddipati KR; Kim S; Heath EI; Granneman J; Podgorski I
Mol Cancer Res; 2019 Dec; 17(12):2508-2521. PubMed ID: 31562254
[TBL] [Abstract][Full Text] [Related]
6. The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.
Chen W; Gao B; Hao L; Zhu G; Jules J; MacDougall MJ; Wang J; Han X; Zhou X; Li YP
J Periodontal Res; 2016 Oct; 51(5):647-60. PubMed ID: 26754272
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
[TBL] [Abstract][Full Text] [Related]
8. The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.
Mizutani K; Sud S; McGregor NA; Martinovski G; Rice BT; Craig MJ; Varsos ZS; Roca H; Pienta KJ
Neoplasia; 2009 Nov; 11(11):1235-42. PubMed ID: 19881959
[TBL] [Abstract][Full Text] [Related]
9. Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment.
Galván GC; Johnson CB; Price RS; Liss MA; Jolly CA; deGraffenried LA
Nutr Cancer; 2017 Oct; 69(7):996-1002. PubMed ID: 28945110
[TBL] [Abstract][Full Text] [Related]
10. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin K inhibitors as treatment of bone metastasis.
Le Gall C; Bonnelye E; Clézardin P
Curr Opin Support Palliat Care; 2008 Sep; 2(3):218-22. PubMed ID: 18685424
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
[TBL] [Abstract][Full Text] [Related]
13. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
14. Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.
Hao L; Chen J; Zhu Z; Reddy MS; Mountz JD; Chen W; Li YP
J Periodontol; 2015 Aug; 86(8):972-83. PubMed ID: 25879791
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
16. Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis.
Kozawa E; Nishida Y; Cheng XW; Urakawa H; Arai E; Futamura N; Shi GP; Kuzuya M; Hu L; Sasaki T; Ishiguro N
Arthritis Rheum; 2012 Feb; 64(2):454-64. PubMed ID: 21968827
[TBL] [Abstract][Full Text] [Related]
17. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?
Podgorski I; Linebaugh BE; Sloane BF
Biochem Soc Trans; 2007 Aug; 35(Pt 4):701-3. PubMed ID: 17635127
[TBL] [Abstract][Full Text] [Related]
19. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
Zhang J; Lu Y; Pienta KJ
J Natl Cancer Inst; 2010 Apr; 102(8):522-8. PubMed ID: 20233997
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer.
Wu N; Wang Y; Wang K; Zhong B; Liao Y; Liang J; Jiang N
Cell Death Dis; 2022 Sep; 13(9):813. PubMed ID: 36138018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
